{"cord_uid": "c0w9bw5u", "sourcedb": "PMC", "sourceid": "PMC4855074", "divid": "16", "text": "To overcome the inactivity of truncation mutants and to define the inhibitory activity of different domains , we decided to create chimeric proteins using domain swapping between MERS - CoV and SARS - CoV M proteins . Particularly , the SN chimera contains the N - terminal transmembrane domains from SARS - CoV M protein and the C - terminal domain from MERS - CoV M protein , whereas the MN chimera contains the N - terminal transmembrane domains from the MERS - CoV M protein and the C - terminal domain from the SARS - CoV M protein ( Figure 5B ) . The breakpoint was designed to occur immediately after the third predicted transmembrane domain at residue 106 and before the conserved Ser residue in both proteins at residue 107 ( Figure 5B ) .", "project": "cdlai_CORD-19", "denotations": [{"id": "A-biobert_T1", "span": {"begin": 30, "end": 49}, "obj": "Gene"}, {"id": "A-biobert_T2", "span": {"begin": 131, "end": 149}, "obj": "Gene"}, {"id": "A-biobert_T3", "span": {"begin": 179, "end": 216}, "obj": "Gene"}, {"id": "A-biobert_T4", "span": {"begin": 237, "end": 248}, "obj": "Gene"}, {"id": "A-biobert_T5", "span": {"begin": 261, "end": 296}, "obj": "Gene"}, {"id": "A-biobert_T6", "span": {"begin": 301, "end": 322}, "obj": "Gene"}, {"id": "A-biobert_T7", "span": {"begin": 330, "end": 350}, "obj": "Gene"}, {"id": "A-biobert_T8", "span": {"begin": 355, "end": 376}, "obj": "Gene"}, {"id": "A-biobert_T9", "span": {"begin": 390, "end": 401}, "obj": "Gene"}, {"id": "A-biobert_T10", "span": {"begin": 414, "end": 449}, "obj": "Gene"}, {"id": "A-biobert_T11", "span": {"begin": 458, "end": 479}, "obj": "Gene"}, {"id": "A-biobert_T12", "span": {"begin": 487, "end": 507}, "obj": "Gene"}, {"id": "A-biobert_T13", "span": {"begin": 516, "end": 537}, "obj": "Gene"}, {"id": "A-biobert_T14", "span": {"begin": 612, "end": 649}, "obj": "Gene"}]}